Skip to main content

H.R. 4106

Referred to Committee

Test Strip Access Act of 2023

Introduced 6/14/2023•118th Congress•House

Latest Action

Referred to the Subcommittee on Health.

6/16/2023 • House

Summary

Test Strip Access Act of 2023 

This bill specifically allows state and tribal opioid response grants, which are administered by the Substance Abuse and Mental Health Services Administration, to be used for fentanyl or xylazine test strips.

Introduced in House • 6/14/2023

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Drug trafficking and controlled substancesDrug, alcohol, tobacco useHealth programs administration and fundingHealth promotion and preventive careMental health

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (3)

Party Breakdown

2
Democrats
1
Republicans
0
Independents

Sponsor

R[
Rep. Crockett, Jasmine [D-TX-30]

Democrat • TX-30

Sponsored 6/14/2023

Cosponsors (2)

R[
Rep. Gooden, Lance [R-TX-5]

R-TX-5

Joined 6/14/2023

R[
Rep. Gallego, Ruben [D-AZ-3]

D-AZ-3

Joined 9/27/2023

Bill Journey

Originated in the House

Introduced

June 14, 2023

Referred to the House Committee on Energy and Commerce.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House6/14/2023

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors2